Session Chair Profile

Ph.D., MSC, DSC, Distinguished University Professor, University of Maryland College Park and Johns Hopkins Bloomberg School of Public Health, President, CosmosID, Inc.

Biography
Rita R. Colwell is a Distinguished University Professor at the University of Maryland and at the Johns Hopkins University Bloomberg School of Public Health. Colwell’s research interests are focused on global infectious diseases, water and health. She is currently developing an international network to address emerging infectious diseases and water issues, including safe drinking water for both the developed and developing world. Colwell served as the 11th director of the National Science Foundation from 1998 to 2004. Her major interests include K–12 sciences and mathematics education, graduate science and engineering education, and the increased participation of women and minorities in science and engineering. She has held many advisory positions in the U.S. government, nonprofit science policy organizations and private foundations, as well as in the international scientific research community. She is a member of the National Academy of Sciences, the Royal Swedish Academy of Sciences, Stockholm, the Royal Society of Canada, the American Academy of Arts and Sciences, and the American Philosophical Society.


 Session Abstract – PMWC 2022 Silicon Valley


Understanding mechanism of action and translating microbiome science into commercially viable therapeutics remains the biggest challenge in this emerging field. With that said, pharma and biotech across many different therapeutic indications and modalities are united in this global effort to bring novel microbiome-based therapies and diagnostics into the clinical domain. This session will include some of the most impactful and promising areas of the Microbiome field and panel discussions on the challenges for faster adoption.

Sessions:

Microbiome and Cancer
Jennifer Wargo, MD Anderon
Sandrine Miller-Montgomery, UCSD

The Gut/Brain Microbiome
Mary Conrad, Axial Biotherapeutics
Chris Reyes, Bloom Science
Rosa Krajmalnik-Brown, Arizona State University

The Role of the Human Gut Microbiome on Various Diseases
Colleen Cutcliffe, Pendulum Therapeutics
Tor Savidge, Baylor College of Medicine
Nikole Kimes, Siolta Therapeutics

Pharma Drug Development
Karim Dabbagh, Second Genome
Ethan Grant, Gilead

Direct-To-Consumer Testing/Technologies
Kiran Krishnan, Microbiome Labs

Regulatory Perspective
Scott Jackson, NIST

Investment Perspective